The Discounted Cash Flow (DCF) valuation of Kuros Biosciences AG (KURN.SW) is (58.44) CHF. With the latest stock price at 22.20 CHF, the upside of Kuros Biosciences AG based on DCF is -363.3%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 4.3% - 7.7% | 6.0% |
| Long-term Growth Rate | 3.0% - 3.9% | 3.4% |
| Fair Price | (330.04) - (32.08) | (58.44) |
| Upside | -1586.6% - -244.5% | -363.3% |